| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.008 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.083 | 0.008 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |